Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology.

Annals of medicine - 1 Dec 2025

Rao Xuan, Wang Yue-Han, Chen Rui-Zhe, Wu Qian-Qian, Zhang Xiao-Fei, Fu Yun-Feng, Wang Xin-Yu, Li Xiao

Abstract excerpt

OBJECTIVE: We attempted to evaluate the immediate high-grade squamous intraepithelial lesion-cervical intraepithelial neoplasia grade 2/3 or worse (HSIL-CIN2+/3+, hereafter referred to as CIN2+/3+) risk of specific human papillomavirus (HPV) genotype and form the precise risk-based triage strategy for atypical squamous cells of undetermined significance (ASC-US) women. METHODS: The clinical data of ASC-US women...

Read the complete abstract on PubMed

Topics

Humans
Female
Triage
Papillomavirus Infections
Adult
Uterine Cervical Dysplasia
Retrospective Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Middle Aged

Uterine Cervical Neoplasms

Genotype

Colposcopy

Atypical Squamous Cells of the Cervix

Papillomaviridae

Early Detection of Cancer

Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 39823191
DOI: 10.1080/07853890.2025.2451183
PMCID: PMC11749152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 16 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology.PMID 39823191Read ↗

Risk-Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real-World Study.Semantic proximity Read ↗

Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.Semantic proximity Read ↗

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.Semantic proximity Read ↗

The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samplesSemantic proximity Read ↗

Utility of Human Papillomavirus Genotyping for Triage of Patients with Atypical Squamous Cells of Undetermined Significance by Cervical Cytology.Semantic proximity Read ↗

Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions.Semantic proximity Read ↗

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.Semantic proximity Read ↗

Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.Semantic proximity Read ↗

Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases.Semantic proximity Read ↗

Eight‐type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV‐positive womenSemantic proximity Read ↗

The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern ChinaSemantic proximity Read ↗

Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.